US4961931A
(en)
*
|
1982-07-29 |
1990-10-09 |
Alza Corporation |
Method for the management of hyperplasia
|
US5208225A
(en)
*
|
1986-02-27 |
1993-05-04 |
Warner-Lambert Company |
Compositions containing fixed combinations
|
IE61236B1
(en)
*
|
1986-07-15 |
1994-10-19 |
American Home Prod |
Combination dosage form for pre-menopausal women
|
CH674618A5
(fr)
*
|
1987-04-02 |
1990-06-29 |
Ciba Geigy Ag |
|
DE3864210D1
(de)
*
|
1987-07-06 |
1991-09-19 |
Akzo Nv |
Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.
|
US4900734A
(en)
*
|
1987-08-27 |
1990-02-13 |
Maxson Wayne S |
Novel pharmaceutical composition containing estradiol and progesterone for oral administration
|
US5108995A
(en)
*
|
1987-09-24 |
1992-04-28 |
Jencap Research Ltd. |
Hormone preparation and method
|
US5276022A
(en)
*
|
1987-09-24 |
1994-01-04 |
Jencap Research Ltd. |
Hormone preparation and method
|
EP0322020A1
(fr)
*
|
1987-12-22 |
1989-06-28 |
Akzo N.V. |
Unité de dosage pharmaceutique pour traiter les troubles climactériques et l'ostéoporose
|
HUT52382A
(en)
*
|
1988-03-14 |
1990-07-28 |
Sandoz Ag |
Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
|
GB8813353D0
(en)
*
|
1988-06-06 |
1988-07-13 |
Ici Plc |
Therapeutic product
|
EP0462189B1
(fr)
*
|
1989-03-10 |
1995-09-27 |
Endorecherche Inc. |
Therapie combinee pour le traitement de maladies sensibles a l'oestrogene
|
US5043331A
(en)
*
|
1989-06-15 |
1991-08-27 |
Orion-Yhtyma Oy |
Treatment of postmenopausal disorders
|
HU222501B1
(hu)
*
|
1991-06-28 |
2003-07-28 |
Endorecherche Inc. |
MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
|
ZA924811B
(en)
*
|
1991-06-28 |
1993-12-29 |
Endorecherche Inc |
Controlled release systems and low dose androgens
|
IL107343A
(en)
*
|
1992-11-02 |
2003-10-31 |
Wyeth Corp |
PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
|
ZA94715B
(en)
*
|
1993-02-08 |
1994-10-24 |
Akzo Nv |
Steroids for treating menopausal complaints
|
US6037339A
(en)
|
1993-02-08 |
2000-03-14 |
Akzo Nobel N.V. |
C-11 substituted steroids for treating menopausal complaints
|
US5710144A
(en)
*
|
1993-02-08 |
1998-01-20 |
Akzo Nobel N.V. |
C-11 substituted steroids for treating menopausal complaints
|
DE4344462C2
(de)
|
1993-12-22 |
1996-02-01 |
Schering Ag |
Zusammensetzung für die Empfängnisverhütung
|
US5759577A
(en)
*
|
1995-01-17 |
1998-06-02 |
American Home Products Corporation |
Controlled release of steroids from sugar coatings
|
US5547948A
(en)
*
|
1995-01-17 |
1996-08-20 |
American Home Products Corporation |
Controlled release of steroids from sugar coatings
|
DE19510861A1
(de)
*
|
1995-03-16 |
1996-09-19 |
Schering Ag |
Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen
|
US5861431A
(en)
*
|
1995-06-07 |
1999-01-19 |
Iotek, Inc. |
Incontinence treatment
|
WO1997004752A1
(fr)
*
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Compositions pharmaceutiques d'oestrogenes conjugues et leurs modes d'emploi
|
FR2737411B1
(fr)
*
|
1995-08-01 |
1997-10-17 |
Theramex |
Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
|
US6040333A
(en)
*
|
1996-07-30 |
2000-03-21 |
Energetics, Inc. |
Dietary supplements
|
US5654011A
(en)
*
|
1996-07-30 |
1997-08-05 |
Energetics, Inc. |
Dietary supplements
|
US5807586A
(en)
*
|
1996-07-30 |
1998-09-15 |
Energetics, Inc. |
Method of dietary supplementation
|
FR2754179B1
(fr)
*
|
1996-10-08 |
1998-12-24 |
Theramex |
Nouvelle composition hormononale et son utilisation
|
US5898032A
(en)
|
1997-06-23 |
1999-04-27 |
Medical College Of Hampton Roads |
Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
|
DE19739916C2
(de)
*
|
1997-09-11 |
2001-09-13 |
Hesch Rolf Dieter |
Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
|
AU4957999A
(en)
*
|
1998-07-17 |
2000-02-07 |
Pharmacia & Upjohn Company |
Subcutaneous medroxyprogesterone acetate for contraception
|
US6165504A
(en)
*
|
1998-09-23 |
2000-12-26 |
Barr Laboratories, Inc. |
Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
|
WO2000021511A2
(fr)
*
|
1998-10-09 |
2000-04-20 |
Pharmacia & Upjohn Company |
Acetate de medroxyprogesterone administre par voie sous-cutanee en vue du traitement de la menopause et de l'endometriose
|
US6613758B1
(en)
|
1999-04-02 |
2003-09-02 |
Barr Laboratories, Inc. |
Method for treating osteoporosis in castrated prostatic cancer patients
|
US6703367B1
(en)
|
1999-04-27 |
2004-03-09 |
Praecis Pharmaceuticals Inc. |
Methods for treating hot flashes and gynaecomastia
|
US6787531B1
(en)
*
|
1999-08-31 |
2004-09-07 |
Schering Ag |
Pharmaceutical composition for use as a contraceptive
|
WO2001030356A1
(fr)
*
|
1999-10-25 |
2001-05-03 |
Laboratoire Theramex |
Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
|
US20020132801A1
(en)
*
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
US7025979B2
(en)
|
2000-02-15 |
2006-04-11 |
Schering Ag |
Male contraceptive formulation comprising norethisterone
|
US7989436B2
(en)
|
2003-07-23 |
2011-08-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and pharmaceutical formulations comprising the same
|
US6660726B2
(en)
|
2000-03-10 |
2003-12-09 |
Endeavor Pharmaceuticals |
Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
|
US6855703B1
(en)
|
2000-03-10 |
2005-02-15 |
Endeavor Pharmaceuticals |
Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
|
US7459445B2
(en)
*
|
2000-03-10 |
2008-12-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and topical pharmaceutical formulations of the same
|
US20010034340A1
(en)
*
|
2000-03-20 |
2001-10-25 |
American Home Products Corporation |
Hormone replacement therapy
|
US20020151530A1
(en)
*
|
2000-12-22 |
2002-10-17 |
Leonard Thomas W. |
Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
|
DE10100911A1
(de)
*
|
2001-01-11 |
2002-08-01 |
Schering Ag |
Verfahren zur Hormonersatztherapie und dessen Darreichungsform
|
US20060142257A1
(en)
*
|
2001-01-19 |
2006-06-29 |
Eberhard Nieschlag |
Male contraceptive formulation comprising norethisterone
|
IL157944A0
(en)
*
|
2001-03-16 |
2004-03-28 |
Wyeth Corp |
Hormone replacement therapy
|
JP2004524354A
(ja)
*
|
2001-03-16 |
2004-08-12 |
ワイス |
エストロゲン補充療法
|
FR2823976A1
(fr)
*
|
2001-04-25 |
2002-10-31 |
Theramex |
Nouvelle composition hormonale et son utilisation
|
US20130203722A1
(en)
|
2006-09-26 |
2013-08-08 |
Rhonda R. Voskuhl |
Estriol therapy for autoimmune and neurodegenerative disease and disorders
|
EP1390038A2
(fr)
*
|
2001-05-16 |
2004-02-25 |
Endeavor Pharmaceuticals |
Traitement d'etats lies a un deficit en hormones par administration de progestatifs
|
EP1406634A1
(fr)
*
|
2001-07-13 |
2004-04-14 |
Schering Aktiengesellschaft |
Combinaison de drospirenone et d'un sulfamate d'oestrogene destinee a une hormonotherapie substitutive
|
WO2003018026A1
(fr)
*
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Utilisation de composes oestrogeniques combines avec des composes progestogeniques dans une hormonotherapie substitutive
|
CA2468748C
(fr)
|
2001-12-05 |
2010-01-26 |
Barr Laboratories, Inc. |
Contraceptifs oraux pour eviter les grossesses et diminuer la symptomatologie premenstruelle
|
US20030191096A1
(en)
*
|
2002-04-03 |
2003-10-09 |
Leonard Thomas W. |
Method of hormonal therapy
|
EP1494679A4
(fr)
*
|
2002-04-03 |
2009-10-28 |
Barr Lab Inc |
Therapie oestrogenique a diminution graduelle
|
TW200306851A
(en)
*
|
2002-04-29 |
2003-12-01 |
Wyeth Corp |
Hormone replacement therapy
|
TW200400040A
(en)
*
|
2002-05-17 |
2004-01-01 |
Wyeth Corp |
Hormone replacement therapy
|
TW200404551A
(en)
*
|
2002-05-17 |
2004-04-01 |
Wyeth Corp |
Hormone replacement therapy
|
RS20050184A
(en)
*
|
2002-08-28 |
2007-11-15 |
Robert Casper |
Estrogen replacement regimen
|
EP1462106A1
(fr)
*
|
2003-03-28 |
2004-09-29 |
Pantarhei Bioscience B.V. |
Compositions pharmaceutiques et trousses comprenant 17-beta estradiol et progesteron pour le traitement des troubles gynecologiques
|
US6992075B2
(en)
*
|
2003-04-04 |
2006-01-31 |
Barr Laboratories, Inc. |
C(14) estrogenic compounds
|
JP2006522833A
(ja)
*
|
2003-04-11 |
2006-10-05 |
バー・ラボラトリーズ,インコーポレイテッド |
エストロゲンおよびプロゲスチンの投与法
|
US7772219B2
(en)
*
|
2003-05-02 |
2010-08-10 |
Teva Women's Health, Inc. |
Methods of hormonal treatment utilizing extended cycle contraceptive regimens
|
CN101001631B
(zh)
*
|
2003-07-16 |
2014-08-06 |
特卫华妇女健康有限公司 |
利用连续给予雌激素的避孕方案的激素治疗方法
|
AU2004275469B2
(en)
|
2003-09-29 |
2010-07-15 |
Novo Nordisk Health Care Ag |
HRT formulations
|
EP1673071A1
(fr)
*
|
2003-09-29 |
2006-06-28 |
Novo Nordisk Femcare AG |
Stabilite amelioree de formulations contenant un progestogene
|
CA2566811A1
(fr)
*
|
2004-05-26 |
2005-12-15 |
Wyeth |
Compositions et methodes pour traiter un trouble dysphorique premenstruel
|
DE102004026669A1
(de)
*
|
2004-05-28 |
2005-12-15 |
Grünenthal GmbH |
Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
|
DE102004026679A1
(de)
*
|
2004-05-28 |
2005-12-15 |
Grünenthal GmbH |
Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
|
US20060040904A1
(en)
*
|
2004-08-17 |
2006-02-23 |
Ahmed Salah U |
Vaginal cream compositions, kits thereof and methods of using thereof
|
US20070111975A1
(en)
|
2004-10-07 |
2007-05-17 |
Duramed Pharmaceuticals, Inc. |
Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
|
EP1853272A1
(fr)
*
|
2005-02-03 |
2007-11-14 |
Duramed Pharmaceuticals, Inc. |
Compositions d'oestrogenes non conjugues et procedes destines a leur utilisation
|
JP2009521533A
(ja)
*
|
2005-12-27 |
2009-06-04 |
デュラメド ファーマシューティカルズ インコーポレーティッド |
結合型エストロゲン組成物、アプリケーター、キット、ならびにそれらの作製および使用の方法
|
AR065816A1
(es)
*
|
2007-03-26 |
2009-07-01 |
Theramex |
Regimen anticonceptivo oral
|
EP2164498A4
(fr)
|
2007-06-04 |
2010-09-08 |
Univ California |
Association d'hormone de grossesse pour le traitement de maladies autoimmunes
|
KR20130097073A
(ko)
|
2010-04-15 |
2013-09-02 |
바이엘 인텔렉쳐 프로퍼티 게엠베하 |
초저-용량의 hrt용 고체 경구 투여 형태
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
PT2782584T
(pt)
|
2011-11-23 |
2021-09-02 |
Therapeuticsmd Inc |
Preparações e terapias de substituição para hormonoterapias naturais combinadas
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
WO2015168000A1
(fr)
*
|
2014-04-28 |
2015-11-05 |
The Regents Of The University Of California |
Combinaison d'oestrogènes pour le traitement de la sclérose en plaques
|
US10369158B2
(en)
|
2014-04-28 |
2019-08-06 |
The Regents Of The University Of California |
Pharmaceutical packaging for estriol therapy
|
AR100562A1
(es)
|
2014-05-22 |
2016-10-12 |
Therapeuticsmd Inc |
Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
|
WO2016036719A1
(fr)
|
2014-09-02 |
2016-03-10 |
The Regents Of The University Of California |
Thérapie oestrogénique pour traitement l'atrophie de la matière grise cérébrale et le handicap associé
|
WO2016053946A1
(fr)
|
2014-09-29 |
2016-04-07 |
The Regents Of The University Of California |
Compositions et méthodes pour améliorer la fonction cognitive
|
WO2016160832A1
(fr)
|
2015-03-30 |
2016-10-06 |
The Regents Of The University Of California |
Méthodes de surveillance de thérapie à base d'œstriol
|
EP3701944B1
(fr)
|
2015-06-18 |
2021-12-08 |
Estetra SRL |
Unité posologique orodispersible contenant un composant d'estétrol
|
CN116077454A
(zh)
|
2015-06-18 |
2023-05-09 |
埃斯特拉有限责任公司 |
含雌四醇组分的口腔分散剂量单位
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
BR112018070199A2
(pt)
|
2016-04-01 |
2019-01-29 |
Therapeuticsmd Inc |
composição farmacêutica de hormônio esteroide
|
WO2017173044A1
(fr)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Compositions d'hormones stéroïdes dans des huiles à chaîne moyenne
|
KR20220144885A
(ko)
|
2016-08-05 |
2022-10-27 |
에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 |
월경통 및 생리통의 관리방법
|
JOP20200260A1
(ar)
|
2018-04-19 |
2019-10-19 |
Estetra Sprl |
مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
|
TWI801561B
(zh)
|
2018-04-19 |
2023-05-11 |
比利時商依思特拉私人有限責任公司 |
化合物及其用於緩解絕經相關症狀的用途
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|